Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / RLMD - Relmada Therapeutics Inc. (RLMD) CEO Sergio Traversa on Q4 2021 Results - Earnings Call Transcript

RLMD - Relmada Therapeutics Inc. (RLMD) CEO Sergio Traversa on Q4 2021 Results - Earnings Call Transcript

Relmada Therapeutics Inc.
Relmada Therapeutics, Inc. (RLMD) Q4 2021 Results Conference Call March 23, 2022 04:30 PM ET Company Participants Tim McCarthy - IR, LifeSci Advisors Sergio Traversa - CEO Maged Shenouda - CFO Conference Call Participants Andrew Tsai - Jefferies Andrea Tan - Goldman Sachs Joon Lee - Truist Securities Yatin Suneja - Guggenheim Jay Olson - Oppenheimer Presentation Operator Greetings, and welcome to the Relmada Therapeutics Fourth Quarter and Full Year 2021 Earnings Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Tim McCarthy of LifeSci Advisors. Thank you, Tim. You may begin. Tim McCarthy Thank you, Paul, and thank you all for joining us this afternoon. With me on today’s call are Chief Executive Officer, Sergio Traversa, and Chief Financial

For further details see:

Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q4 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Relmada Therapeutics Inc.
Stock Symbol: RLMD
Market: OTC
Website: relmada.com
Menu
RLMD RLMD Quote RLMD Short RLMD News RLMD Articles RLMD Message Board
Get RLMD Alerts

News, Short Squeeze, Breakout and More Instantly...